Global Capillary Blood Collection Devices Market Research Report – Forecast Till 2023

Global Capillary Blood Collection Devices Market Research Report – Forecast Till 2023

$4450 – $6250

Global Capillary Blood Collection Devices Market Research Report: By Material (Plastic, Glass, Stainless Steel, and Others), Type of Devices (Blood Collecting Tubes and Collector, Lancets, Warming Devices, and Others), End-User – Forecast Till 2023

SKU: 180475 Category: Tags: , , , , , , , , , , , , , , , , , , , , , , ,

Description

Market Analysis
Blood Collection for testing assumes a fundamental role in an effective medical treatment at the hospitals, healthcare and diagnostic centers all over the world. Blood test accumulation method incorporates a chain of sequence, and each sequence of this grouping is very imperative to keep up high-quality clinical outcomes. Global capillary blood collection devices market is anticipated to grow at a CAGR of 10.0% during the forecast period 2017–2023.
It has been noticed that the medical device regulation is the key factor driving the growth of the capillary blood collection devices market. Control of the usage of a medical device must be upgraded and improvised to protect the well-being of the patient. It must be ensured that high-quality products and effective technologies reach the patients. Developing interest for analysis of chronic diseases, the rising prevalence of diabetes, and expanding geriatric populace are additionally energizing the market development. However, the higher risk related to the capillary blood assortment technologies leading to blood contaminations may restrict the growth of the capillary blood collection devices market.
Market Segmentation
The global capillary blood collection devices market is divided on the basis of its type of devices, material, and end-user industry. On the basis of its type of devices, the global capillary blood collection devices market is bifurcated into lancets, blood collecting tubes and collector, and warming devices. Based on its material, the global market is classified into glass, plastic, stainless steel, and others. Based on its end -user, the market is sectioned into clinics, hospitals, home diagnostics, diagnostic centers and pathology laboratories, and others.
Regional Analysis
Geographically, the global capillary blood collection devices market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
Major Players
Some of major players in the capillary blood collection devices market include companies like F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Novo Nordisk A S, Medtronic PLC, B. Braun Melsungen AG, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Ypsomed Holding AG, Terumo Corporation, HTL-STREFA S.A., Sarstedt AG & Co, Greiner Bio-One, Owen Mumford Ltd., Improve Medical, Weigao Group, Chengdu Rich Science Industry Co., Ltd., Nipro, Weihai Hongyu Medical Devices, Medigard, and others.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

Table of Contents: 1 Report Prologue 2 Market Introduction 2.1 Assumptions & Limitations 2.1.1 Assumptions 2.1.2 Limitations 3 Research Methodology 3.1 Primary Research Methodology 3.2 Secondary Research Methodology 3.3 Market Share Analysis 3.4 Trade Analysis 3.5 Market Pricing Approach 4 Market Dynamics 4.1 Introduction 4.2 Drivers 4.2.1 Growing demand for diagnosis of chronic disease 4.2.2 Rising prevalence of diabetes leading to high demand of lancets 4.2.3 Favorable Medical Device Regulation 4.2.4 Increasing Geriatric Population 4.3 Restraint 4.3.1 Risk Associated With Capillary Blood Assortment Techniques and Blood Contaminations 4.4 Opportunity 4.4.1 Technological advancement 4.5 Megatrend 4.6 Macroeconomic Indicators 5 Market Impact Analysis 5.1 Porters Five Forces Analysis 5.1.1 Bargaining Power of Suppliers 5.1.2 Bargaining Power of Buyers 5.1.3 Threat of New Entrants 5.1.4 Threat of Substitutes 5.1.5 Intensity of Rivalry 5.2 Supply chain analysis 5.2.1 R&D 5.2.2 Parts Manufacturing 5.2.3 Distribution 5.2.4 Marketing & Sales 5.2.5 Post-Sales Monitoring 5.3 Demand & Supply: Gap Analysis 5.4 Pricing Analysis 5.5 Investment Opportunities 6 Global Capillary Blood Collection Devices Market by Material 6.1 Introduction 6.1.1 Plastic 6.1.2 Glass 6.1.3 Stainless Steel 7 Global Capillary Blood Collection Devices Market by Type of Devices 7.1 Introduction 7.1.1 Blood Collecting Tubes and Collector 7.1.2 Lancets 7.1.3 Warming Devices 8 Global Capillary Blood Collection Devices Market by End-User 8.1 Introduction 8.1.1 Hospitals & Clinics 8.1.2 Diagnostic Centres and Pathology Laboratories 8.1.3 Home Diagnostics 9 Global Capillary Blood Collection Devices Market by Region 9.1 Introduction 9.2 Americas 9.2.1 North America 9.2.1.1 U.S. 9.2.1.2 Canada 9.2.2 South America 9.3 Europe 9.3.1 Western Europe 9.3.1.1 Germany 9.3.1.2 France 9.3.1.3 U.K. 9.3.1.4 Italy 9.3.1.5 Spain 9.3.1.6 Rest of Western Europe 9.3.2 Eastern Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Republic of Korea 9.4.5 Australia 9.4.6 Rest of Asia Pacific 9.5 Middle East & Africa 9.5.1 United Arab Emirates 9.5.2 Saudi Arabia 9.5.3 Oman 9.5.4 Kuwait 9.5.5 Qatar 9.5.6 Rest of Middle East & Africa 10 Company Landscape 10.1 Company Market Share Analysis 10.1.1 Introduction 10.2 Competitive Strategies 10.2.1 Introduction 11 Company Profiles 11.1 F. Hoffmann-La Roche AG 11.1.1 Company Overview 11.1.2 Financials 11.1.3 Products 11.1.4 Strategy 11.1.5 Key Developments 11.2 Danaher Corporation 11.2.1 Company Overview 11.2.2 Financials 11.2.3 Products 11.2.4 Strategy 11.2.5 Key Developments 11.3 Abbott Laboratories 11.3.1 Company Overview 11.3.2 Financials 11.3.3 Products 11.3.4 Strategy 11.3.5 Key Developments 11.4 Novo Nordisk A S 11.4.1 Company Overview 11.4.2 Financials 11.4.3 Products 11.4.4 Strategy 11.4.5 Key Developments 11.5 Becton Dickinson 11.5.1 Company Overview 11.5.2 Financials 11.5.3 Products 11.5.4 Strategy 11.5.5 Key Developments 11.6 Medtronic PLC 11.6.1 Company Overview 11.6.2 Financials 11.6.3 Products 11.6.4 Strategy 11.6.5 Key Developments 11.7 B. Braun Melsungen AG 11.7.1 Company Overview 11.7.2 Financials 11.7.3 Products 11.7.4 Strategy 11.7.5 Key Developments 11.8 Thermo Fisher Scientific Inc. 11.8.1 Company Overview 11.8.2 Financials 11.8.3 Products 11.8.4 Strategy 11.8.5 Key Developments 11.9 Terumo Corporation 11.9.1 Company Overview 11.9.2 Financials 11.9.3 Products 11.9.4 Strategy 11.9.5 Key Developments 11.1 Ypsomed Holding AG 11.10.1 Company Overview 11.10.2 Financials 11.10.3 Products 11.10.4 Strategy 11.10.5 Key Developments 11.11 HTL-STREFA S.A. 11.11.1 Company Overview 11.11.2 Financials 11.11.3 Products 11.11.4 Strategy 11.11.5 Key Developments 11.12 Sarstedt AG & Co 11.12.1 Company Overview 11.12.2 Financials 11.12.3 Products 11.12.4 Strategy 11.12.5 Key Developments 11.13 Owen Mumford Ltd. 11.13.1 Company Overview 11.13.2 Financials 11.13.3 Products 11.13.4 Strategy 11.13.5 Key Developments 11.14 Greiner Bio One 11.14.1 Company Overview 11.14.2 Financials 11.14.3 Products 11.14.4 Strategy 11.14.5 Key Developments 11.15 Improve Medical 11.15.1 Company Overview 11.15.2 Financials 11.15.3 Products 11.15.4 Strategy 11.15.5 Key Developments 12 Conclusion 12.1 Key Findings 12.1.1 From CEO’s View Point 12.2 Key Companies to Watch 13 Appendix 13.1 Discussion Blue Print 13.1 Recent Developments, 2014-2017

Related products